Welcome to Iris Biotech
For better service please confirm your country and language we detected.
Währung
EUR
Schneller Kontakt
Bitte senden Sie mir mehr Informationen über
Fmoc-L-Asn(1G,2GN)-OH
Chemischer Name: N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N4-((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4R,5S,6R)-3-acetamido-5-(((2S,3S,4S,5R,6R)-4-(((2R,3S,4S,5S,6R)-3-(((2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-( hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy // Synonyme: Fmoc-Asn(1G,2GN)-OH, Common glycan name: G1 [6], Oxford glycan name: A2[6]G1, Alternative Glycan name: A2G1, GlyCosmos ID: G89993FE
- Art-Nr.:GCN1100
- CAS Nr.:491845-04-6
- Lagertemperatur:-20°C
- Formel:C75H110N6O45
- Molare Masse:1815,70 g/mol
- Reinheit:min.90,0%
Ab 560,00 €
description
Fmoc-protected Asn-linked A2G1 glycan for use in solid phase peptide synthesis (SPPS).
references
Prompt Chemoenzymatic Synthesis of Diverse Complex-Type Oligosaccharides and Its Application to the Solid-Phase Synthesis of a Glycopeptide with Asn-Linked Sialyl-undeca- and Asialo-nonasaccharides; Y. Kjihara, Y. Suzuki, N. Yamamoto, K. Sasaki, T. Sakakibara, L. R. Juneja; Chem. Eur. J. 2004; 10: 971-985. https://doi.org/10.1002/chem.200305115
Chemical Synthesis of Homogeneous Human Glycosyl-interferon-â That Exhibits Potent Antitumor Activity in Vivo; I. Sakamoto, K. Tezuka, K. Fukae, K. Ishii, K. Taduru, M. Maeda, M. Ouchi, K. Yoshida, Y. Nambu, J. Igarashi, N. Hayashi, T. Tsuji, Y. Kajihara; J. Am. Chem. Soc. 2012; 134: 5428−5431. https://doi.org/10.1021/ja2109079
Benötigen Sie weitere Informationen über dieses Produkt?
kontaktieren Sie uns
Produkte, die Sie auch interessieren könnten!
